Search Results - "Sender L"

Exploring the interior of cuticles and compressions of fossil plants by FIB-SEM milling and image microscopy.

Authors: SENDER, L. M. ESCAPA, I. BENEDETTI, A. et al.

Source: Journal of Microscopy. Jan2018, Vol. 269 Issue 1, p48-58. 11p.

Metformin: a cheap and well-tolerated drug that provides benefits for viral infections.

Authors: Joven, J Menéndez, JA Fernandez‐Sender, L et al.

Source: HIV Medicine. Apr2013, Vol. 14 Issue 4, p233-240. 8p. 2 Charts, 3 Graphs.

501P Bayesian selection of lipidome dynamics features for a K-nearest neighbors (KNN) classifier model of tumor response in patients with advanced gastrointestinal (GI) adenocarcinoma undergoing systemic treatment.

Authors: Valentí, V. Ramos, J. Fernández-Sender, L. et al.

Source: Annals of Oncology. 2025 Supplement 1, Vol. 36, pS188-S188. 1p.

IL-2-activated cord blood mononuclear cells.

Authors: Derzic, S. Slone, V. Sender, L.

Source: Cytotherapy (Taylor & Francis Ltd). Oct2005, Vol. 7 Issue 5, p408-416. 9p.

Leukocyte cell population data (volume conductivity scatter) in postprandial leukocyte activation.

Authors: Klop, B. Geijn, G.‐J. M. Njo, T. L. et al.

Source: International Journal of Laboratory Hematology. Dec2013, Vol. 35 Issue 6, p644-651. 8p.

Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.

Authors: Janes, M R Vu, C Mallya, S et al.

Source: Leukemia (08876924). Mar2013, Vol. 27 Issue 3, p586-594. 9p. 5 Graphs.

Pitfalls in measuring high-density lipoprotein cholesterol concentrations in HIV-infected patients.

Authors: Aragonès, G. Beltrán, R. Rull, A. et al.

Source: HIV Medicine. Apr2010, Vol. 11 Issue 4, p260-265. 6p. 1 Graph.

Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.

Authors: Abu-Ghosh, A Goldman, S Slone, V et al.

Source: Bone Marrow Transplantation. 9/1/99, Vol. 24 Issue 5, p535. 10p.

Collection and use of peripheral blood stem cells in young children with refractory solid tumors.

Authors: Shen, V Woodbury, C Killen, R et al.

Source: Bone Marrow Transplantation. 2/1/97, Vol. 19 Issue 3, p197. 8p.

Testicular tissue cryopreservation: 8 years of experience from a coordinated network of academic centers.

Authors: Valli-Pulaski, H Peters, K A Gassei, K et al.

Source: Human Reproduction. Jun2019, Vol. 34 Issue 6, p966-977. 12p. 1 Diagram, 4 Charts, 2 Graphs, 1 Map.

415 MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND PARAOXONASE-1 IN PERIPHERAL ARTERIAL DISEASE: A MODEL OF INTERACTION BETWEEN DEFENSE AGAINST OXIDATIVE STRESS AND INFLAMMATION

Authors: Rull, A. García, R. Fernández-Sender, L. et al.

Source: Atherosclerosis (Supplements). Jun2011, Vol. 12 Issue 1, p89-89. 1p.

Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML).

Authors: Neudorf, S. Nourani, A. Kempert, P. et al.

Source: Bone Marrow Transplantation. May2004, Vol. 33 Issue 10, p1069-1069. 1p.

358P - Complete responses in patients with second-line or greater metastatic triple negative breast cancer (TNBC) following first-in-human immunotherapy combining NK and T cell activation with off-the-shelf high-affinity CD16 NK cell line (haNK).

Authors: Nangia, C. Soon-Shiong, P. Rabizadeh, S. et al.

Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv130-v130. 1p.

P334 HIV INFECTION INDUCES MAJOR CHANGES IN HDL PARTICLE SIZE DISTRIBUTION AND COMPOSITION: THE EFFECT OF ANTIRETROVIRAL TREATMENT AND DISEASE SEVERITY

Authors: Aragones, G. Beltrán-Debón, R. Rull, A. et al.

Source: Atherosclerosis (Supplements). Jun2010, Vol. 11 Issue 2, p87-88. 2p.

406 THE DELETERIOUS INFLUENCE OF TENOFOVIR-BASED THERAPIES ON THE PROGRESSION OF ATHEROSCLEROSIS IN HIV-INFECTED PATIENTS

Authors: Araqones, G. Pardo, P. Beltrán-Debon, R. et al.

Source: Atherosclerosis (Supplements). Jun2011, Vol. 12 Issue 1, p87-87. 1p.

Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet).

Authors: Bansal A Stoffel EM Lim R et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 19; Vol. 17, pp. 1809281. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026).

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Reply by Authors.

Authors: Chang SS Chamie K Kramolowsky E et al.

Source: The Journal of urology [J Urol] 2026 Jan; Vol. 215 (1), pp. 52-53. Date of Electronic Publication: 2025 Oct 24.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE; In Process

Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.

Authors: Chang SS Chamie K Kramolowsky E et al.

Source: The Journal of urology [J Urol] 2026 Jan; Vol. 215 (1), pp. 44-56. Date of Electronic Publication: 2025 Sep 16.

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study

Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

Recurrent pancreatic cancer treated with N-803 and PD-L1 t-haNK followed by an EGFR-targeted nanocell drug conjugate.

Authors: Moini K Seery T Nangia C et al.

Source: The oncologist [Oncologist] 2025 Mar 10; Vol. 30 (3).

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients.

Authors: Seery T Sender L Jafari O et al.

Source: Frontiers in oncology [Front Oncol] 2025 Jan 29; Vol. 15, pp. 1472714. Date of Electronic Publication: 2025 Jan 29 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE